Goodrays has extended its range outside CBD drinks with a product the UK business said can support “cognitive performance”.
The London-based firm has launched Re:Focus, a “functional drink” containing lion’s mane, magnesium and electrolytes.
Goodrays has secured listings for a four-pack of 330ml cans at Morrisons and Waitrose, as well as on Amazon.
The drinks, which have a recommended retail price of £7.50 ($10.05), are available in two flavours: Zesty Lime and Kiwi; and Wild Mixed Berry Mix.
“Having spent the last decade in the CBD industry and with our CBD range growing 45% year-on-year, Re:Focus is a milestone moment for us and is a first-to-market product in the UK due to the effective doses of magnesium, lion’s mane and electrolytes included,” Goodrays founder Eoin Keenan said. “We believe that functionality should never come at the cost of flavour, which is why delivering delicious taste remains at the heart of everything we create.”
The drinks contain 800mg of magnesium, 250mg of lion’s mane and a blend of 530mg of electrolytes. Goodrays said the recipes have “twice the amount of magnesium and lion’s mane to other similar drinks available on the market”. The ingredients can "help reduce tiredness" and "support memory, focus and long-term brain health", the company added.
Last year, rival CBD drinks business Trip widened its range with the launch of Mindful Blend, a line of beverages containing ashwagandha, L-theanine, lion’s mane and magnesium.
In July, Goodrays raised £5m in a new funding round led by venture-capital firm Guinness Ventures. The company also appointed former Liquid Death executive Ben Dando as its new managing director.
Goodrays, set up in 2020, already has listings with major UK grocers including Tesco, Sainsbury’s and Morrisons. It has also crossed the English Channel into France, where its CBD drinks are sold at retailers including Carrefour and Intermarché.
CBD products have been classified as novel foods in the UK since January 2019, requiring evaluation and authorisation before being legally marketed.
In an interview with Just Drinks in August, Keenan said he expects "full market authorisation" next year.
